Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Avecho Biotechnology Ltd V.AVE


Primary Symbol: AVEFF

Avecho Biotechnology Limited is an Australia-based biopharmaceutical company. The Company develops and commercializes human and animal health products using its drug delivery system called Tocopheryl Phosphate Mixture (TPM). TPM is derived from vitamin E using patented processes. The Company's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health portfolio covers delivery of pharmaceutical products through gels, injectables and patches, including conduct of research and development activities. The Company's products pipeline includes Weaner Pig Starter TPM Premix, Poultry TPM Premix, Dairy TPM Premix, Daptomycin, Propofol and Veterinary Applications. The Company is also developing TPM to enhance feed efficiency and the health of livestock. Its TPM products are commercialized under license: Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.


OTCPK:AVEFF - Post by User

Post by kijijion Apr 19, 2018 4:27pm
215 Views
Post# 27913757

AVE Provides Update on Shareholder Meeting

AVE Provides Update on Shareholder Meeting
CALGARY, Alberta, April 19, 2018 (GLOBE NEWSWIRE) -- Aveda Transportation and Energy Services Inc. (“Aveda” or the “Company”) (AVE.V), one of North America’s largest dedicated rig moving companies, provides the following update regarding the proposed shareholder meeting described in its press release of April 16, 2018 to consider approval of a business combination with Daseke, Inc.,  a leading consolidator and the largest owner of flatbed and specialized transportation and logistics solutions in North America (the “Transaction”).  Aveda has now set the date of its special meeting of shareholders to consider approval of the Transaction to be May 30, 2018, and has also set the record date for shareholders entitled to vote at the meeting to be April 30, 2018.  Further details regarding the proposed Transaction are contained in Aveda’s press release of April 16, 2018.
 
 
<< Previous
Bullboard Posts
Next >>